10 January 2023
QV Bioelectronics Raises £2m to Develop Revolutionary Electric Field Therapy Implant for Brain Tumour Treatment
10th January 2022, Cheshire, UK £2M Pre-Series A financing raised from new and existing VCs. The funds will facilitate the completion of pre-clinical studies and the…
8 August 2022
Sabine Ficek Joins QV Bio as new CFO
We are delighted to announce that Sabine Ficek has joined our growing team QV Bioelectronics as CFO! Sabine is a seasoned CFO with 25 years of experience within Finance…
1 June 2022
QV Bioelectronics CEO Dr Chris Bullock Gives Evidence as an Industry Expert to the All-Party Parliamentary Group on Brain Tumours (APPGBT)
The All-Party Parliamentary Group on Brain Tumours (APPGBT) held a fifth oral evidence session today as part of its ongoing inquiry, Pathway to a Cure – breaking down…
4 February 2022
QV Bioelectronics Awarded £630,000 Under Innovate UK Biomedical Catalyst Award for implanted electric field therapy device for brain cancer treatment.
Funding will accelerate development of the GRACE implant to treat brain tumour patients with electric field therapy. The project will accelerate the collection of…
18 November 2021
Liz Freeman Joins QV as Finance/HR Manager
We’re delighted to welcome our newest addition to the team Liz Freeman! Liz is an experienced Finance/HR Manager and brings a wealth of skills and…
2 November 2021
Welcome to the new QV Bioelectronics website!
Welcome to the new QV Bioelectronics website! Our new site aims to more closely reflect our vision at QV Bioelectronics, which is to deliver longer,…
Interested in Receiving our Press Releases?